₹32.56
▼ -0.31 -0.94%
17 Jul 2026
BSE Listed
ESM 1ANG Lifesciences India Limited (540694)
Volume: 4,606Avg Vol 1W: 3,779Avg Vol 1M: 21,56252W Range:₹17.63₹49.69
Key Ratios
Checked just nowMarket Cap₹43 Cr
Current Price₹32.56
Previous Close₹32.87
High / Low (52w)₹49.69 / ₹17.63
Volume4,606
Avg Vol (1W)3,779
Avg Vol (1M)21,562
Stock P/E—
Book Value₹40.5
Dividend Yield0%
ROE-20.96%
ROA-5.31%
Revenue (TTM)—
Revenue Growth—
Profit Margin-11.94%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0.8
Debt / Equity1.11
50 DMA₹30.94
200 DMA₹28.41
Day change-0.94%
SurveillanceESM 1 (as of 2026-07-17)
Price Chart
₹32.56▲ 2.68% · 1Y
2025-07-162026-07-16
20-day avg volume: 23K shares
Pros
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 35% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹18 Cr | ₹33 Cr | ₹25 Cr | ₹17 Cr | ₹25 Cr | ₹26 Cr | ₹19 Cr | ₹24 Cr |
| EBITDA | ₹-2 Cr | ₹1 Cr | ₹-4 Cr | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr | ₹-4 Cr | ₹1 Cr |
| Net Profit | ₹-3 Cr | ₹-2 Cr | ₹-5 Cr | ₹-2 Cr | ₹-2 Cr | ₹-3 Cr | ₹-5 Cr | ₹-1 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Revenue | ₹355 Cr | ₹230 Cr | ₹147 Cr | ₹95 Cr |
| EBITDA | ₹62 Cr | ₹15 Cr | ₹2 Cr | ₹-7 Cr |
| Net Profit | ₹40 Cr | ₹0 Cr | ₹-10 Cr | ₹-12 Cr |
| EPS | 39.09 | 0.36 | -7.61 | -9.42 |
Balance Sheet
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Total Assets | ₹291 Cr | ₹278 Cr | ₹242 Cr | ₹230 Cr |
| Total Liabilities | ₹207 Cr | ₹191 Cr | ₹166 Cr | ₹166 Cr |
| Equity | ₹84 Cr | ₹86 Cr | ₹76 Cr | ₹64 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Operating | ₹25 Cr | ₹30 Cr | ₹4 Cr | ₹4 Cr |
| Investing | ₹-44 Cr | ₹-9 Cr | ₹20 Cr | ₹-2 Cr |
| Financing | ₹20 Cr | ₹-17 Cr | ₹-10 Cr | ₹2 Cr |
| Free Cash Flow | ₹25 Cr | ₹30 Cr | ₹4 Cr | ₹4 Cr |
Shareholding
Promoter 70.6% Institutions 0% Public 29.4%
Efficiency & Working Capital
ROCE-3.8%
Interest Coverage-0.7
Dividend Payout—
Debtor Days262 d
Inventory Days213 d
Payable Days260 d
Cash Conversion Cycle215 d
Working Capital Days474 d
Shareholding Details
As of 2026-03-31
Promoter70.6%
FII0%
DII0%
Institutions0%
Public29.4%
Promoter Pledge44.9%
No. of Shareholders5,952
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% | 29.4% |
| Promoter Pledge | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% | 44.9% |
| No. of Shareholders | 7,305 | 7,055 | 6,918 | 6,868 | 6,631 | 6,468 | 6,517 | 6,508 | 6,400 | 6,273 | 6,084 | 5,952 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Rajesh Gupta | Shareholding of Promoter and Promoter Group | 70.4% | 91,94,537 |
| Saruchi Gupta | Shareholding of Promoter and Promoter Group | 0.2% | 25,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Rajesh Gupta | 41,37,500 | 45% | 2026-03-31 |
| Saruchi Gupta | 0 | 0% | 2026-03-31 |
| Rajesh Gupta | 41,37,500 | 45% | 2025-12-31 |
| Saruchi Gupta | 0 | 0% | 2025-12-31 |
| Rajesh Gupta | 41,37,500 | 45% | 2025-09-30 |
| Saruchi Gupta | 0 | 0% | 2025-09-30 |
| Rajesh Gupta | 41,37,500 | 45% | 2025-06-30 |
| Saruchi Gupta | 0 | 0% | 2025-06-30 |
| Rajesh Gupta | 41,37,500 | 45% | 2025-03-31 |
| Saruchi Gupta | 0 | 0% | 2025-03-31 |
| Rajesh Gupta | 41,37,500 | 45% | 2024-12-31 |
| Saruchi Gupta | 0 | 0% | 2024-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Rajesh Gupta | Executive Director & MD | 2025 |
| Saruchi Gupta | Executive Director / Whole Time Director / CFO | 2025 |
| Rohit Mittal | Non Executive Director | 2025 |
| Harvinder Singh Dhami | Independent Non Exe. Director | 2025 |
| Sukhpal Singh | Independent Non Exe. Director | 2025 |
| Chetna | Independent Non Exe. Director | 2025 |
| Harshita Aggarwal | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹5 Cr | 5.6% |
| Within India | ₹85 Cr | 94.4% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 14 | 13 | 13 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 9 | 0 | 0 | 19 | 10 | 37 |
| 2025 | 4 | 0 | 0 | 17 | 0 | 21 |
| 2025 | 2 | 0 | 0 | 1 | 0 | 4 |
Company Information
🌐 www.anglifesciences.com ↗
📍 Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block, Amritsar, Punjab, 143001
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search